Atlas Venture Life Science Advisors, LLC has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $443 Million distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $277M, Dyne Therapeutics, Inc. with a value of $116M, Day One Biopharmaceuticals, Inc. with a value of $45.3M, Generation Bio Co. with a value of $5.07M, and Disc Medicine, Inc. with a value of $0.

Examining the 13F form we can see an decrease of $11.6M in the current position value, from $455M to 443M.

Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $443 Million
Healthcare: $443 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $443 Million
  • Prior Value $455 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.